Last Price
20.61
Today's Change
+0.53 (2.63%)
Day's Change
19.12 - 21.90
Trading Volume
63,056
Market Cap
134 Million
Shares Outstanding
6 Million
Avg Volume
143,688
Avg Price (50 Days)
29.47
Avg Price (200 Days)
20.92
PE Ratio
-1.78
EPS
-11.56
Earnings Announcement
19-Mar-2025
Previous Close
20.08
Open
19.97
Day's Range
19.12 - 21.9
Year Range
6.88 - 92.0
Trading Volume
62,678
1 Day Change
2.64%
5 Day Change
-6.36%
1 Month Change
-16.76%
3 Month Change
-68.89%
6 Month Change
99.52%
Ytd Change
165.25%
1 Year Change
201.32%
3 Year Change
-93.30%
5 Year Change
-96.10%
10 Year Change
-96.10%
Max Change
-96.10%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.